Detalhe da pesquisa
1.
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma.
Blood;
131(7): 746-758, 2018 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29284597
2.
Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice.
Blood;
124(24): 3624-35, 2014 Dec 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25258341
3.
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.
Front Immunol;
12: 618610, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33717112
4.
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma.
Clin Cancer Res;
26(13): 3443-3454, 2020 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32220887
5.
Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing.
J Clin Pathol;
71(10): 895-899, 2018 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29760015
6.
Surgical removal of an atypical macular epiretinal membrane in neurofibromatosis type 2: clinicopathologic correlation and visual outcome.
Arch Ophthalmol;
130(10): 1337-9, 2012 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23044955